IHAI Has Patents On The Battery Tech Automakers Are Paying Top Dollar For

Every battery ever built forces the same trade-off between energy density for endurance and power output for performance, because the electrode design that stores the most charge is the same one that slows its release. Nearly two decades and tens of billions of dollars have gone into solid state, silicon anode, and sodium ion looking for a chemistry that does both, and none of it has produced one. Premergy (OTCID: $IHAI) holds granted patents that solve the problem from outside the cell entirely, leaving the chemistry alone and splitting the job across two batteries instead.

IHAI's architecture pairs two battery banks of different chemistries inside the same pack, one built for steady cruising range and the other for hard pulls and fast recharge, and puts a controller between them that decides which bank the machine draws from moment to moment, so the machine gets both sides of the choice a single cell cannot make. A second family of claims, granted as recently as January 2025, covers adaptive regeneration, which drops the battery side's voltage the moment the vehicle decelerates so charge keeps flowing at crawl speeds where conventional systems have already stopped collecting. A third rewires the pack on the fly, running the banks in series to drive the motor and flipping them to parallel to recharge. The company reports the three working together return gains north of 20% out of the same pack, with no change to the cells themselves.

IHAI names four end markets its patents reach into, covering electric vehicles, AI infrastructure and data centers, drones, and grid-scale storage, all of them feeding a battery management market Fortune Business Insights valued at $13.64 billion in 2025 and projected to grow to $51.78 billion by 2034. Drones are the nearest, because flight time is an energy problem and charge turnaround is a power problem, a drone maker today has to pick between them, and a supplier can be qualified in a fraction of the time an automaker takes, which is why the Clemson program now covers drone battery and charging work and management has commenced discussions with multiple drone and UAV manufacturers. The largest is the AI buildout, where a rack of accelerators draws a steady baseline and then slams into surge during training runs, the same split the dual-bank architecture was designed around, and where Gartner projects 40% of existing AI data centers will be constrained by power availability by 2027.

The smartest piece of the whole story is how IHAI set itself up to get paid. In March the board moved the portfolio, more than twenty issued and pending patents, into Premergy IP Solutions, a wholly owned subsidiary built to hold it, so a license is written against the portfolio itself. QuantumScape (NASDAQ: $QS) reached the same destination the expensive way, spending years and billions on factories before landing on a licensing deal with Volkswagen (OTCQX: $VWAGY) subsidiary PowerCo carrying an initial royalty fee of $130 million, and it is worth roughly $4 billion while still pre-revenue. Most microcaps announcing a licensing strategy spend the year after that building this structure, but IHAI already has it in place.

While IHAI carries a market cap of under $10 million, buying into the battery control layer has cost others as much as nine figures. Fortescue (OTCQX: $FSUGY) paid £164 million for the Williams-descended engineering house whose Elysia unit advertises up to 30% longer usable battery life from algorithms alone, and Volvo (OTCID: $VLVOF) built Breathe's charging software into its new generation of electric cars after taking a stake in the company. The 20% IHAI reports sits in the band those buyers paid into, attached to patents a manufacturer can license instead of a company it would have to buy. Qnovo has raised north of $40 million on a portfolio of more than 60 patents, with Hyundai (OTCID: $HYMTF) and Kia (OTCID: $KIMTF) joining BorgWarner (NYSE: $BWA) on its backer list this spring and Preqin marking it near $88 million, and each of these companies is selling battery gains out of the same layer IHAI's patents occupy, which makes them the first doors a licensing team knocks on rather than just valuation benchmarks.

A licensing company needs three things done, the business run, the technology built, and the capital raised, and each seat at IHAI holds someone who has already done that job. Michael Pruitt took the chief executive role in March while holding the interim CEO seat at Forward Industries (NASDAQ: $FWDI), and he has run small public companies since founding the merchant bank Avenel Financial Group in 1999, including fifteen years at the top of the restaurant group Chanticleer Holdings. Richard Botts, the chief technology officer, is the named inventor across the portfolio and is still adding to it, with the newest grant landing in January 2025. His own stake, a voting trust in his name, and the 30 million shares held by Premergy, Inc. together keep most of the company in the hands of the people behind the technology. William Hayde, an investment banker for three decades, put the patent acquisition together as chief executive, and the executive chairman seat keeps him on the capital side as the company pushes toward its stated goal of an uplist.

The path forward from here is short and already in motion. A Series C preferred financing has closed with accredited investors to fund the validation, IP development, and business development that turn a portfolio into a royalty stream. A corporate name change to Premergy is filed with a new ticker to follow, the company is working toward full SEC reporting status, and the stated plan is an uplist, the step that opens the stock to funds and analysts who cannot touch an OTC name today. Clemson's evaluation runs alongside the discussions management is already in with drone and UAV manufacturers, and any one of those conversations turning into a signature starts a royalty stream at a company with no factory to run, no inventory to finance, no production line to feed, and no bet riding on which chemistry finally wins.

---

Disclaimer: Mt. Zion Market Ventures has received compensation for the creation and dissemination of this article. For more information, please visit opendisclose.com. The information provided here is not intended to be a comprehensive analysis of the subjects mentioned. All information, opinions, and forecasts contained herein should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities or related financial instruments. Investors should conduct their own research or consult with a qualified financial advisor before making any investment decisions. The author and publisher of this content are not responsible for any losses, damages, or other consequences that may result from the use of the information provided. Investing in stocks, including those mentioned here, involves risks, including the risk of loss.